Evidence map›Paper›PMID 42834897›Full record

ReviewBiodesign research2026

Recent advances in AI-driven deep eutectic solvent design for biocatalysis: Co-design of extremozyme and reaction medium.

Yuxuan Hou, Jinyu Meng, Binghui Chen, Jifeng Yuan, Shizhen Wang

Abstract readReview
In one paragraph

Review in Biodesign research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuxuan HouSchool of Computing and Data Science, Xiamen University Malaysia, Sepang, Selangor, 43900, Malaysia.
Jinyu MengDepartment of Chemical and Biochemical Engineering, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China.
Binghui ChenDepartment of Chemical and Biochemical Engineering, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China.
Jifeng YuanState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Fujian, China.
Shizhen WangDepartment of Chemical and Biochemical Engineering, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep eutectic solvents (DES) have emerged as sustainable, highly tunable alternatives to conventional organic media for non-aqueous biocatalysis. DES dynamically interact with enzymes to shift reaction equilibria, enhance thermostability and tailor stereoselectivity. However, the vast combinatorial space and complex physicochemical properties of DES make traditional trial-and-error solvent engineering highly inefficient. This review systematically examines recent advancements in DES-driven biocatalysis and highlights the role of artificial intelligence (AI) for rational DES design. Specifically, it synthesizes evidence that DES composition and water content jointly shape enzyme-specific microenvironments and thereby affect catalytic performance. Extremozymes are also evaluated as candidate catalysts for DES-containing media and as sources of potentially transferable adaptation features for enzyme engineering. It then discusses how AI can support DES formation screening, prediction of physicochemical properties using quantitative structure-property relationship (QSPR) models, and candidate formulation generation at the solvent level. At the system level, the focus shifts to predicting how a specific enzyme responds to a defined formulation in terms of activity and stability. Finally, we outline a mechanistically informed, multi-objective framework that integrates DES composition, enzyme sequence and structure, and operating conditions with physicochemical calculations, AI-based prediction, and experimental validation, providing a practical route toward genuine DES-enzyme co-design.

Indexed as

Artificial intelligenceBiocatalysisDeep eutectic solventsExtremozymesSolvent engineering

Identifiers

PMID42834897
PMCPMC13634743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.